KARISSA MILLER: Open Payments
NPI 1023532108 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 25 payments from 13 companies in 2025. Trend: 2023 $865 · 2024 $862 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $243 |
| BIOTRONIK INC. | 2 | $172 |
| Abbott Laboratories | 1 | $156 |
| Medtronic, Inc. | 1 | $116 |
| Novo Nordisk Inc | 4 | $80 |
| PFIZER INC. | 4 | $63 |
| Kestra Medical Technology Services, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $25 |
Products named: ENSITE, Solia, FARAPULSE, General - Therapies, AFFERA MAPPING SYSTEM, ELIQUIS, Assure WCD, Ozempic.
Industry payments across IN — which companies pay providers there.
